We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Meridian Showcases Innovative Solutions for Molecular Diagnostics and Immunoassays

By LabMedica International staff writers
Posted on 11 Nov 2024

Meridian Bioscience (Cincinnati, OH, USA) is presenting its innovative solutions in molecular and immunoassay reagents that are designed to simplify assay design, eliminate cold-chain logistics, and improve sustainability. The company is also highlighting its large portfolio of antigens, antibodies, blockers, molecular enzymes, nucleotides, and optimized mixes for qPCR, isothermal amplification, and NGS applications for the IVD industry.

Meridian’s glycerol-free, high-concentration molecular reagents, and services enable the development of ambient-temperature stable assays, eliminating the need for cold chain logistics and ensuring robust and seamless supply chains. This reduces energy consumption in transit and storage as well as minimizes packaging requirements, particularly the use of refrigerant, dry ice, and expanded polystyrene foam. Meridian’s extraction-free, low-temperature molecular solutions streamline workflows by eliminating the need for multiple reagent-based extraction steps and reducing the overall energy consumption required for high-temperature processes. Streamlined workflows with fewer steps result in faster turnaround times and increased throughput, reducing operational energy and resource use. Additionally, Meridian’s animal-free recombinant alternatives for immunoassays (blockers, antibodies, and antigens) can offer greater versatility and reproducibility over animal immunization, ensuring continuity of supply while alleviating ethical concerns.


Image: Meridian is presenting its innovative solutions in molecular and immunoassay reagents at MEDICA 2024 (Photo courtesy of Meridian)
Image: Meridian is presenting its innovative solutions in molecular and immunoassay reagents at MEDICA 2024 (Photo courtesy of Meridian)

Meridian is highlighting its recently launched glycerol-free NGS enzymes, further establishing the company as a leader in developing innovative, eco-conscious, and cost-effective components for diagnostic assay developers. Visitors to Meridian’s booth at the show can also learn about the company’s introduction of the market’s first innovative lyophilized Next-Generation Sequencing (NGS) library preparation kit. This revolutionary lyophilized NGS library preparation kit, designed initially for sequencing by synthesis (SBS) protocols, marks a breakthrough in stabilizing the library preparation process at room temperature. The pioneering kit can be transported and stored at ambient temperature and contains ready-to-use lyophilized reactions to simplify the end-repair, A-tailing, ligation, and library amplification steps of most sequencing protocols. By eliminating the requirement for cold-chain shipping and storage, Meridian’s innovative kit not only simplifies logistical and environmental challenges but also significantly reduces carbon emissions and operational costs, thereby streamlining the entire NGS workflow.

Related Links:
Meridian Bioscience


New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Urine Drug Test
Instant-view Methadone Urine Drug Test

Latest Medica 2024 News

EDAN Instruments Highlights Range of Lab Analyzers, ECG Devices and Ultrasound Systems

BioVendor Group Introduces Groundbreaking Immunological Biomarker

Getein Biotech Showcases Latest POCT Analyzers